Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

63%

5 of 8 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 4

3(33.3%)

N/A

3(33.3%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

9Total

Phase 4(3)

N/A(3)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04755595Phase 2Completed

Combination Facial Aesthetic Treatment in Millennials

Role: collaborator

NCT03518034Phase 4Completed

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Role: collaborator

NCT02392026Phase 4Completed

Safety and Tolerability of Metronidazole Gel 1.3%

Role: collaborator

NCT04819321Not ApplicableUnknown

Study of White Adipose Tissue Remodeling by Cryolipolysis in Humans

Role: collaborator

NCT03931785Phase 2Completed

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Role: collaborator

NCT03573908Phase 3Completed

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Role: collaborator

NCT03661697Not ApplicableCompleted

Combination Versus Laser Treatment Only

Role: collaborator

NCT03332342Not ApplicableCompleted

Closed Eye Neutrophils in Dry Eye Disease

Role: collaborator

NCT03180593Phase 4Completed

Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH

Role: collaborator

All 9 trials loaded